BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36737428)

  • 1. Glycolysis-related lncRNA TMEM105 upregulates LDHA to facilitate breast cancer liver metastasis via sponging miR-1208.
    Han J; Chen X; Wang J; Liu B
    Cell Death Dis; 2023 Feb; 14(2):80. PubMed ID: 36737428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effect.
    Li L; Kang L; Zhao W; Feng Y; Liu W; Wang T; Mai H; Huang J; Chen S; Liang Y; Han J; Xu X; Ye Q
    Cancer Lett; 2017 Aug; 400():89-98. PubMed ID: 28461244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of lncRNA-NEAT1 sensitizes 5-Fu resistant cervical cancer cells through de-repressing the microRNA-34a/LDHA axis.
    Shao X; Zheng X; Ma D; Liu Y; Liu G
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 33645623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-489 suppresses multiple myeloma cells growth through inhibition of LDHA-mediated aerobic glycolysis.
    Wu H; Wang X; Wu T; Yang S
    Genes Genomics; 2020 Mar; 42(3):291-297. PubMed ID: 31872383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-33b inhibits osteosarcoma cell proliferation through suppression of glycolysis by targeting Lactate Dehydrogenase A (LDHA).
    Zheng XM; Xu CW; Wang F
    Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):31-35. PubMed ID: 30213286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA HAGLR sponges miR-338-3p to promote 5-Fu resistance in gastric cancer through targeting the LDHA-glycolysis pathway.
    Hu J; Huang L; Ding Q; Lv J; Chen Z
    Cell Biol Int; 2022 Feb; 46(2):173-184. PubMed ID: 34658120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NUSAP1-LDHA-Glycolysis-Lactate feedforward loop promotes Warburg effect and metastasis in pancreatic ductal adenocarcinoma.
    Chen M; Cen K; Song Y; Zhang X; Liou YC; Liu P; Huang J; Ruan J; He J; Ye W; Wang T; Huang X; Yang J; Jia Y; Liang X; Shen P; Wang Q; Liang T
    Cancer Lett; 2023 Jul; 567():216285. PubMed ID: 37354982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT3/LINC00671 axis regulates papillary thyroid tumor growth and metastasis via LDHA-mediated glycolysis.
    Huo N; Cong R; Sun ZJ; Li WC; Zhu X; Xue CY; Chen Z; Ma LY; Chu Z; Han YC; Kang XF; Jia SH; Du N; Kang L; Xu XJ
    Cell Death Dis; 2021 Aug; 12(9):799. PubMed ID: 34404767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53/Lactate dehydrogenase A axis negatively regulates aerobic glycolysis and tumor progression in breast cancer expressing wild-type p53.
    Zhou Y; Niu W; Luo Y; Li H; Xie Y; Wang H; Liu Y; Fan S; Li Z; Xiong W; Li X; Ren C; Tan M; Li G; Zhou M
    Cancer Sci; 2019 Mar; 110(3):939-949. PubMed ID: 30618169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H19 promotes aerobic glycolysis, proliferation, and immune escape of gastric cancer cells through the microRNA-519d-3p/lactate dehydrogenase A axis.
    Sun L; Li J; Yan W; Yao Z; Wang R; Zhou X; Wu H; Zhang G; Shi T; Chen W
    Cancer Sci; 2021 Jun; 112(6):2245-2259. PubMed ID: 33756038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ErbB2 promotes breast cancer metastatic potential via HSF1/LDHA axis-mediated glycolysis.
    He L; Lv S; Ma X; Jiang S; Zhou F; Zhang Y; Yu R; Zhao Y
    Med Oncol; 2022 Jan; 39(4):45. PubMed ID: 35092510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer.
    Xiao X; Huang X; Ye F; Chen B; Song C; Wen J; Zhang Z; Zheng G; Tang H; Xie X
    Sci Rep; 2016 Feb; 6():21735. PubMed ID: 26902416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA MCF2L-AS1 aggravates proliferation, invasion and glycolysis of colorectal cancer cells via the crosstalk with miR-874-3p/FOXM1 signaling axis.
    Zhang Z; Yang W; Li N; Chen X; Ma F; Yang J; Zhang Y; Chai X; Zhang B; Hou X; Luo S; Hua Y
    Carcinogenesis; 2021 Feb; 42(2):263-271. PubMed ID: 32860508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circ-CSNK1G1 promotes cell proliferation, migration, invasion and glycolysis metabolism during triple-negative breast cancer progression by modulating the miR-28-5p/LDHA pathway.
    Zan X; Li W; Wang G; Yuan J; Ai Y; Huang J; Li Z
    Reprod Biol Endocrinol; 2022 Sep; 20(1):138. PubMed ID: 36109751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer.
    Wang J; Wang H; Liu A; Fang C; Hao J; Wang Z
    Oncotarget; 2015 Aug; 6(23):19456-68. PubMed ID: 26062441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking circ-CNST suppresses malignant behaviors of osteosarcoma cells and inhibits glycolysis through circ-CNST-miR-578-LDHA/PDK1 ceRNA networks.
    Hu R; Chen S; Yan J
    J Orthop Surg Res; 2021 May; 16(1):300. PubMed ID: 33962616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-361-5p inhibits glycolytic metabolism, proliferation and invasion of breast cancer by targeting FGFR1 and MMP-1.
    Ma F; Zhang L; Ma L; Zhang Y; Zhang J; Guo B
    J Exp Clin Cancer Res; 2017 Nov; 36(1):158. PubMed ID: 29132384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA FGD5‑AS1 promotes breast cancer progression by regulating the hsa‑miR‑195‑5p/NUAK2 axis.
    Fang K; Xu ZJ; Jiang SX; Tang DS; Yan CS; Deng YY; Zhao FY
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA colorectal neoplasia differentially expressed promotes glycolysis of liver cancer cells by regulating hypoxia-inducible factor 1α.
    Tang D; Zhao L; Mu R; Ao Y; Zhang X; Li X
    Chin J Physiol; 2022; 65(6):311-318. PubMed ID: 36588357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of lactate dehydrogenase a by 14-3-3ζ leads to increased glycolysis critical for breast cancer initiation and progression.
    Chang CC; Zhang C; Zhang Q; Sahin O; Wang H; Xu J; Xiao Y; Zhang J; Rehman SK; Li P; Hung MC; Behbod F; Yu D
    Oncotarget; 2016 Jun; 7(23):35270-83. PubMed ID: 27150057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.